CYTOF · Altamira Therapeutics Ltd. · Documents
Market Cap
$514,392
Shares
5.72M
Volume · Oct 20
1600
Avg daily vol (3M)
5272
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2022-10-24 | — | |
| 6-K | — | 2022-10-24 | — | |
| 6-K | — | 2022-09-29 | — | |
| 6-K | — | 2022-09-12 | — | |
| 6-K | — | 2022-08-30 | — | |
| 6-K | — | 2022-08-26 | — | |
| 6-K | — | 2022-06-27 | — | |
| 6-K | — | 2022-06-13 | — | |
| 6-K | — | 2022-06-07 | — | |
| 6-K | — | 2022-05-19 | — | |
| 6-K | — | 2022-05-17 | — | |
| 6-K | — | 2022-04-18 | — | |
| 20-F | — | 2022-04-12 | 2021-12-31 | |
| 6-K | — | 2022-03-04 | — | |
| 6-K | — | 2022-02-08 | — | |
| 6-K | — | 2021-12-16 | — | |
| 6-K | — | 2021-09-08 | 2021-06-30 | |
| 6-K | — | 2021-07-23 | 2021-07-22 | |
| 6-K | — | 2021-07-21 | — | |
| 6-K | — | 2021-06-16 | — | |
| 6-K | — | 2021-06-03 | — | |
| 6-K | — | 2021-05-17 | — | |
| 6-K | — | 2021-04-16 | — | |
| 6-K | — | 2021-04-13 | — | |
| 6-K | — | 2021-03-31 | — | |
| 20-F | — | 2021-03-31 | 2020-12-31 | |
| 6-K | — | 2021-03-12 | — | |
| 6-K | — | 2021-01-15 | — | |
| 6-K | — | 2020-12-10 | — | |
| 6-K | — | 2020-12-03 | — | |
| 6-K | — | 2020-12-02 | — | |
| 6-K | — | 2020-10-09 | — | |
| 6-K | — | 2020-09-17 | 2020-06-30 | |
| 6-K/A | — | 2020-09-17 | 2020-06-30 | |
| 6-K | — | 2020-09-11 | — | |
| 6-K | — | 2020-09-08 | — | |
| 6-K | — | 2020-07-02 | — | |
| 6-K | — | 2020-06-05 | — | |
| 6-K | — | 2020-04-23 | — | |
| 6-K | — | 2020-04-23 | — | |
| 6-K | — | 2020-04-21 | — | |
| 20-F | — | 2020-04-16 | 2019-12-31 | |
| 6-K | — | 2020-04-16 | — | |
| 6-K | — | 2020-01-09 | — |
Showing 51–94 of 94 filings